NYSE:GMRE

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$958.4m

Last Updated

2021/08/03 00:44 UTC

Data Sources

Company Financials +

Executive Summary

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share. More Details


Snowflake Analysis

Adequate balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has Global Medical REIT's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GMRE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: GMRE's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

-1.9%

GMRE

-0.1%

US REITs

-0.4%

US Market


1 Year Return

32.1%

GMRE

31.8%

US REITs

34.4%

US Market

Return vs Industry: GMRE exceeded the US REITs industry which returned 30.6% over the past year.

Return vs Market: GMRE underperformed the US Market which returned 35.9% over the past year.


Shareholder returns

GMREIndustryMarket
7 Day-1.9%-0.1%-0.4%
30 Day3.0%3.1%-0.4%
90 Day9.5%8.0%4.0%
1 Year40.0%32.1%36.2%31.8%36.5%34.4%
3 Year122.2%79.6%44.4%28.2%62.0%51.9%
5 Year113.1%43.6%52.5%23.1%121.8%97.2%

Long-Term Price Volatility Vs. Market

How volatile is Global Medical REIT's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Global Medical REIT undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GMRE ($15.32) is trading below our estimate of fair value ($58.27)

Significantly Below Fair Value: GMRE is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GMRE is unprofitable, so we can't compare its PE Ratio to the US REITs industry average.

PE vs Market: GMRE is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GMRE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GMRE's PB Ratio (1.8x) is in line with the US REITs industry average.


Future Growth

How is Global Medical REIT forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

31.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GMRE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: GMRE is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: GMRE's is expected to become profitable in the next 3 years.

Revenue vs Market: GMRE's revenue (18.1% per year) is forecast to grow faster than the US market (9.2% per year).

High Growth Revenue: GMRE's revenue (18.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GMRE's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Global Medical REIT performed over the past 5 years?

19.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GMRE is currently unprofitable.

Growing Profit Margin: GMRE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: GMRE is unprofitable, but has reduced losses over the past 5 years at a rate of 19.5% per year.

Accelerating Growth: Unable to compare GMRE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GMRE is unprofitable, making it difficult to compare its past year earnings growth to the REITs industry (-9.1%).


Return on Equity

High ROE: GMRE has a negative Return on Equity (-0.33%), as it is currently unprofitable.


Financial Health

How is Global Medical REIT's financial position?


Financial Position Analysis

Short Term Liabilities: GMRE's short term assets ($44.8M) exceed its short term liabilities ($36.6M).

Long Term Liabilities: GMRE's short term assets ($44.8M) do not cover its long term liabilities ($503.9M).


Debt to Equity History and Analysis

Debt Level: GMRE's debt to equity ratio (83.8%) is considered high.

Reducing Debt: GMRE's debt to equity ratio has reduced from 630.8% to 83.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable GMRE has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: GMRE is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 47.7% per year.


Dividend

What is Global Medical REIT current dividend yield, its reliability and sustainability?

5.35%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GMRE's dividend (5.35%) is higher than the bottom 25% of dividend payers in the US market (1.32%).

High Dividend: GMRE's dividend (5.35%) is in the top 25% of dividend payers in the US market (3.55%)


Stability and Growth of Payments

Stable Dividend: GMRE has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: GMRE's dividend payments have increased, but the company has only paid a dividend for 7 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (149.1%), GMRE's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GMRE's dividends in 3 years are forecast to be covered by earnings (75.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Jeff Busch (61 yo)

4yrs

Tenure

US$3,086,109

Compensation

Mr. Jeffrey M. Busch, also known as Jeff, is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharmaceuticals, Inc.). since June 2020. He is the Chairman of Avant Diagnos...


CEO Compensation Analysis

Compensation vs Market: Jeff's total compensation ($USD3.09M) is about average for companies of similar size in the US market ($USD2.44M).

Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: GMRE's management team is considered experienced (4.3 years average tenure).


Board Members

Experienced Board: GMRE's board of directors are considered experienced (5.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.8%.


Top Shareholders

Company Information

Global Medical REIT Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Global Medical REIT Inc.
  • Ticker: GMRE
  • Exchange: NYSE
  • Founded: 2011
  • Industry: Health Care REITs
  • Sector: Real Estate
  • Implied Market Cap: US$958.390m
  • Market Cap: US$931.367m
  • Shares outstanding: 62.56m
  • Website: https://www.globalmedicalreit.com

Number of Employees


Location

  • Global Medical REIT Inc.
  • 2 Bethesda Metro Center
  • Suite 440
  • Bethesda
  • Maryland
  • 20814
  • United States

Listings


Biography

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with le...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/08/03 00:44
End of Day Share Price2021/08/02 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.